日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial

瑞戈非尼联合信迪利单抗作为微卫星稳定型转移性结直肠癌的挽救治疗：一项单臂、开放标签的II期临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-56748-3
Liu, Rui; Ji, Zhi; Wang, Xia; Zhu, Lila; Xin, Jiaqi; Ma, Lijun; Zhang, Jiayu; Ge, Shaohua; Zhang, Le; Yang, Yuchong; Ning, Tao; Bai, Ming; Duan, Jingjing; Wang, Feixue; Sun, Yansha; Li, Hongli; Deng, Ting; Ba, Yi; Hao, Jihui
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Correction: Inhibition of ferroptosis counteracts the advanced maternal age-induced oocyte deterioration

更正：抑制铁死亡可以抵消高龄产妇引起的卵母细胞退化。

期刊:Cell Death and Differentiation
影响因子:15.4
doi:10.1038/s41418-025-01519-2
Zeng, Wenjun; Wang, Feixue; Cui, Zhaokang; Zhang, Yu; Li, Yu; Li, Na; Mao, Zipeng; Zhang, Hanwen; Liu, Yiting; Miao, Yilong; Sun, Shaochen; Cai, Yafei; Xiong, Bo
细胞生物学
铁死亡
发表日期：2025
文献求助 收藏

Inhibition of ferroptosis counteracts the advanced maternal age-induced oocyte deterioration.

抑制铁死亡可以抵消高龄产妇引起的卵母细胞退化

期刊:Cell Death and Differentiation
影响因子:15.4
doi:10.1038/s41418-025-01456-0
Zeng Wenjun, Wang Feixue, Cui Zhaokang, Zhang Yu, Li Yu, Li Na, Mao Zipeng, Zhang Hanwen, Liu Yiting, Miao Yilong, Sun Shaochen, Cai Yafei, Xiong Bo
细胞生物学
铁死亡
发表日期：2025
文献求助 收藏

Polygonatum sibiricum Delar. ex Redoute: A Potential Functional Food for the Prevention and Treatment of Hyperuricemia

西伯利亚黄精（Polygonatum sibiricum Delar. ex Redoute）：一种用于预防和治疗高尿酸血症的潜在功能性食品

期刊:Food Science & Nutrition
影响因子:3.8
doi:10.1002/fsn3.70985
Zhao, Peng; Liu, Wenjing; He, Minyang; Cao, Weiyou; Xu, Qichang; Hao, Qing; Wang, Lijun; Liu, Ying; Wang, Jingyu; Wang, Feixue; Jiang, Lin; Li, Songze; Dai, Chunyan; Zheng, Qiusheng; Ma, Jun; Fan, Xiangcheng; Han, Jichun
发表日期：2025
文献求助 收藏

The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center.

抗 PD-1 抗体、曲妥珠单抗和化疗的联合应用可能改善 HER2 阳性甲胎蛋白产生型胃癌患者的预后：来自单中心的回顾性真实世界分析。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14808-3
Ge Shaohua, Wang Feixue, Li Hongli, Yang Yuchong, Zhang Le, Duan Jingjing, Bai Ming, Liu Rui, Ning Tao, Wang Xia, Ji Zhi, Sun Yansha, Deng Ting
胃癌
心血管
PD-1
HER2
发表日期：2025
文献求助 收藏

Temporal interference stimulation for human brain: Opportunities and challenges

时间干扰刺激对人脑的影响：机遇与挑战

期刊:
影响因子:
doi:10.1016/j.xinn.2025.100803
Wang, Feixue; Jiang, Mingyan; Deng, Demao; Tu, Yiheng
神经科学
发表日期：2025
文献求助 收藏

A multipath error cancellation method based on antenna jitter

一种基于天线抖动的多径误差消除方法

期刊:Communications Engineering
影响因子:
doi:10.1038/s44172-025-00355-z
Liu, Jiyang; Wang, Feixue; Tang, Xiaomei; Wang, Sixin; Yuan, Muzi
发表日期：2025
文献求助 收藏

Treatment strategies for patients with HER2-positive gastric cancer

HER2阳性胃癌患者的治疗策略

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2023.0480
Wang, Feixue; Ba, Yi
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2024
文献求助 收藏

Erratum to Treatment strategies for patients with HER2-positive gastric cancer

关于 HER2 阳性胃癌患者治疗策略的勘误

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2024.0070
Wang, Feixue; Ba, Yi
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2024
文献求助 收藏

Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study

齐贝利单抗联合乐伐替尼和化疗治疗甲胎蛋白升高的晚期胃癌患者（AFPGC）：一项1期剂量递增研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03743-0
Deng, Ting; Wang, Feixue; Zhang, Le; Ning, Tao; Sun, Yansha; Ge, Shaohua; Bai, Ming; Lu, Yao; Li, Hongli; Ba, Yi
肿瘤
肿瘤免疫
胃癌
发表日期：2024
文献求助 收藏